Susceptibility evolution to antibiotics of Enterobacter cloacae, Morganella morganii, Klebsiella aerogenes and Citrobacter freundii involved in urinary tract infections: an 11-year epidemiological surveillance study

Enferm Infecc Microbiol Clin (Engl Ed). 2020 Apr;38(4):166-169. doi: 10.1016/j.eimc.2019.07.010. Epub 2019 Oct 10.
[Article in English, Spanish]

Abstract

Introduction: The objective of this study was to analyse the susceptibility to antibiotic of Citrobacter freundii, Klebsiella aerogenes, Enterobacter cloacae, Serratia marcescens, Providencia stuartii and Morganella morganii (CESPM group), detected in urine cultures.

Methods: Between 2006 and 2016 we analyzed CESPM group Enterobacteria isolated from urine cultures from both primary health-care centers and Hospital Virgen de las Nieves (Granada). We studied the susceptibility to aminoglycosides, fosfomycin, nitrofurantoin, quinolones, piperacillin/tazobactam, cefepime, imipenem and trimethoprim/sulfamethoxazole following CLSI interpretation criteria.

Results: A total of 736 isolates were studied: 30.57% E. cloacae, 23.50% M. morganii, 20.38% K. aerogenes, 10.32% C. freundii, 8.83% S. marcescens and 6.38% P. stuartii. A significant decrease in the antibiotic susceptibility was observed. Gentamicin, ciprofloxacin, imipenem and cefepime showed susceptibility over 80%.

Conclusions: E. cloacae, M. morganii and K. aerogenes were the most common isolates. Cefepime and imipenem are still a good empiric therapeutic alternative given its activity in vitro.

Keywords: AmpC β-lactamases; Enterobacteriaceae; Infección del tracto urinario; Urinary tract infections; β-lactamasas AmpC.

MeSH terms

  • Anti-Bacterial Agents / pharmacology
  • Citrobacter freundii / drug effects
  • Drug Resistance, Bacterial*
  • Enterobacter aerogenes / drug effects
  • Enterobacter cloacae / drug effects
  • Humans
  • Microbial Sensitivity Tests
  • Morganella morganii / drug effects
  • Providencia / drug effects
  • Serratia marcescens / drug effects
  • Spain
  • Urinary Tract Infections* / microbiology

Substances

  • Anti-Bacterial Agents

Supplementary concepts

  • Providencia stuartii